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Background: Paediatric high grade glioma (pHGG) and diffuse intrinsic pontine glioma (DIPG) are highly aggressive brain
tumours. Their invasive phenotype contributes to their limited therapeutic response, and novel treatments that block brain tumour
invasion are needed.
Methods: Here, we examine the migratory characteristics and treatment effect of small molecule glycogen synthase kinase-3
inhibitors, lithium chloride (LiCl) and the indirubin derivative 6-bromoindirubin-oxime (BIO), previously shown to inhibit the
migration of adult glioma cells, on two pHGG cell lines (SF188 and KNS42) and one patient-derived DIPG line (HSJD-DIPG-007)
using 2D (transwell membrane, immunofluorescence, live cell imaging) and 3D (migration on nanofibre plates and spheroid
invasion in collagen) assays.
Results: All lines were migratory, but there were differences in morphology and migration rates. Both LiCl and BIO reduced
migration and instigated cytoskeletal rearrangement of stress fibres and focal adhesions when viewed by immunofluorescence. In
the presence of drugs, loss of polarity and differences in cellular movement were observed by live cell imaging.
Conclusions: Ours is the first study to demonstrate that it is possible to pharmacologically target migration of paediatric glioma
in vitro using LiCl and BIO, and we conclude that these agents and their derivatives warrant further preclinical investigation as
potential anti-migratory therapeutics for these devastating tumours.
Paediatric high grade glioma (pHGG) and diffuse intrinsic pontine
glioma (DIPG) are highly aggressive tumours associated with
dismal prognosis. Paediatric high grade gliomas account for 8–12%
of all primary paediatric CNS tumours (Jones et al, 2012). Current
treatment regimens involve maximal surgical resection, radiation
therapy and chemotherapy. However, despite this intensive
treatment approach, 5-year survival remains between 15 and 35%
(Broniscer and Gajjar, 2004). Diffuse intrinsic pontine gliomas are
the most common brainstem tumours of childhood and represent
one of the most challenging paediatric tumours to treat. Surgery is
not an option, chemotherapeutics have failed to improve out-
comes, and radiotherapy can only temporarily slow disease
progression, which is associated with median survival of less than
1 year (Warren, 2012). Both pHGG and DIPG are known to have
diffuse infiltrative growth patterns, and this invasive phenotype
contributes to their limited therapeutic response (Demuth and
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Berens, 2004; Louis, 2006). As a result, there is a pressing clinical
need to develop novel therapeutic approaches that effectively
reduce such paediatric brain tumour migration and invasion.
Adult HGG cells are known to migrate in specific patterns,
following the orientation of white matter tracts, capillaries and
unmyelinated axons (Louis, 2006; Agudelo-Garcia et al, 2011).
Recent studies have suggested that glycogen synthase kinase-3
(GSK-3), a serine/threonine protein kinase, plays a key role in
orchestrating cell migration, through regulating cellular structure,
motility and dynamics of the cytoskeleton (Grimes and Jope, 2001;
Wakefield et al, 2003; Sun et al, 2009). The effects of small
molecule GSK-3 inhibitors on blocking adult glioma migration and
invasion have been demonstrated both in vitro and in vivo
(Nowicki et al, 2008; Williams et al, 2011) and offer a potential
novel anti-invasive approach for glioma. The effects of GSK-3
inhibitors on pHGG and DIPG migration and invasion are
unknown, and given the distinct biological and clinical phenotype
of the adult and paediatric diseases (Jones et al, 2012), warrant
separate investigation.
Very few studies have focused on identifying existing or novel
therapeutic agents that are capable of impairing migration and
invasion in pHGG and DIPG owing to limited patient tissue
availability. We have conducted a comprehensive analysis of cell
migration in two pHGG cell lines and one rare patient-derived
DIPG cell line using a range of 2D and 3D assays. In addition, we
also demonstrate for the first time that treatment with the small
molecule GSK-3 inhibitors, lithium chloride (LiCl) and the
indirubin derivative 6-bromoindirubin-oxime (BIO), which have
previously been shown to block migration of adult glioma cells
(Nowicki et al, 2008; Williams et al, 2011), also inhibit the
migration of pHGG and DIPG cells in vitro. These agents represent
novel anti-invasive candidates that may improve the clinical
management of these challenging diseases in children.
MATERIALS AND METHODS
Cell lines and reagents. Paediatric glioma cell lines SF188
(Grade IV, Glioblastoma) and KNS42 (Grade IV, Glioblastoma)
were obtained from Dr Chris Jones (Institute of Cancer Research,
London, UK). Cells were grown in Dulbecco’s Modified Eagles’
medium (Sigma-Aldrich, Dorset, UK) with 10% heat-inactivated
foetal calf serum (Labtech, East Sussex, UK) and 0.5% penicillin-
streptomycin (Sigma-Aldrich). Cell line identity was verified by
serial tandem repeat profiling at the University of Leeds. The
patient autopsy-derived DIPG cell line HSJD-DIPG-007 was
obtained from Dr Angel M. Carcaboso (Hospital Sant Joan de
De´u Barcelona, Barcelona, Spain). Cells were cultured as tumour
spheres in tumour stem base medium (Life Technologies, Paisley,
UK) supplemented with B-27 (Life technologies) and human
growth factors EGF, FGF-basic, PDGF-AA and PDGF-BB
(Peprotech, Rocky Hill, NJ, USA). All cell lines were free of
mycoplasma contamination.
Reagents used were LiCl (Sigma-Aldrich) and BIO (Calbiochem,
Nottingham, UK).
Three-dimensional cell migration/invasion assay. For three-
dimensional spheroid cultures, 1 103 cells were incubated for
72 h in an ultra-low attachment round bottom 96-well plate
(Costar, Corning Lifesciences, Tewksbury, MA, USA). Aggregates
were then encased in 100 ml of rat tail collagen-1 (BD Biosciences)
neutralised with 1 M sodium hydroxide (NaOH) in 5 Dulbecco’s
Modified Eagles’ medium. After polymerisation at 37 1C, the
collagen was overlaid with 100 ml of standard growth med-
ium±GSK-3 inhibitors over a range of concentrations. Spheroid
expansion and invasion into the collagen matrix was monitored for
72 h using the EVOS cell imaging system (Advanced Microscopy
Group, Life Technologies) and analysed with Volocity 3D Image
Analysis software (Perkin-Elmer Inc., Coventry, UK) and Image J
(http://rsbweb.nih.gov/ij). In order to quantify migration, two
zones of migration were defined: the invasion zone represents the
area outside the spheroid core to where approximately 75% of
migrating cells invaded into, whereas the leading edge zone
represents the total area containing migrated cells
(Supplementary Figure 1). This method has been previously
described (Ma et al, 2011) and improved the accuracy of the
analysis. The migration index was calculated as
area of zone area of core
total area
Transwell migration assay. Transwell assays were performed
using 8mm pore inserts (Greiner Bio-One, Stroud, UK) pre-coated
with 5mgml 1 of the chemo-attractant fibronectin (Sigma). Cell
lines were pre-treated ±20mM LiCl or 5 mM BIO for 1 h. Cells
(5 104) were then placed into transwell inserts in triplicate and
allowed to migrate for 4 h. Migrated cells were fixed with 1%
glutaraldehyde (Sigma-Aldrich) in PBS and visualised by staining
with 0.1mgml 1 DAPI (Biotium, Hayward, CA, USA). Migration
was determined by imaging DAPI nuclear stain with the EVOS
imaging system and quantifying the fluorescence signal for the
individual transwells using Volocity 3D Image Analysis software.
Migration on nanofibre scaffolds. To evaluate migration on 3D
nanofibre scaffolds, 1 103 cells labelled with Cell Tracker Green
dye (Invitrogen, Paisley, UK) were cultured as hanging drops as
described (Del Duca et al, 2004). Spheroid aggregates were
transferred into wells of aligned poly-e-caprolactone nanofibre-
coated culture plates (Nanofibre solutions, Columbus, OH, USA),
which allows cell migration on a 3D scaffold stimulated by
topographical cues (Johnson et al, 2009). Spheroids were incubated
at 37 1C in growth medium±20mM LiCl or 5mM BIO in triplicate
and migration was monitored for 72 h using the EVOS imaging
system and quantified using Image J software.
Immunofluorescence (IF) and western blotting. Antibodies
for IF studies were rat anti-alpha tubulin monoclonal
antibody (Serotec, Kidlington, UK), rabbit anti-b-catenin antibody
(Sigma-Aldrich) and secondary antibodies (Alexa Fluor-conju-
gated reagents obtained from Molecular Probes, Paisley, UK). For
the identification of focal adhesions, a staining kit (Millipore,
Nottingham, UK) was used. Actin filament and nuclear staining
was performed with rhodamine-phalloidin (Molecular Probes, Life
Technologies) and DAPI (Molecular Probes, Life Technologies) at
recommended working concentrations. For western blotting,
proteins (40 mg) were separated by SDS–PAGE and transferred to
nitrocellulose. Antibodies used were anti-GSK-3b, anti-phospho-
GSK-3b (Ser9) (Cell Signaling, Danvers, MA, USA), anti-GSK-
3aþ b (phospho Y279þY216) (Abcam, Cambridge, UK) and
secondary antibodies as per manufacturer instructions (Dako,
Cambridgeshire, UK).
Live cell imaging. Cells in 500 ml of growth medium±20mM LiCl
or 5 mM BIO were placed in each quarter of an Ibidi imaging dish
(Nikon, Du¨sseldorf, Germany) and cultured in the incubation/
imaging chamber of the Nikon Biostation IM time lapse imaging
system. Cells were imaged for 24 h at 3-min intervals at 37 1C with
5% CO2 in air. The Biostation IM associated software was used to
create movie files for analysis. Cell tracking was performed in
Image J with MTrackJ (www.imagescience.org/meijering/software/
mtrackj/). For tracking, the nucleus of each cell was identified and
tracked over 24 h at 150min intervals.
Cell viability and proliferation analysis. Cell viability of both
monolayers and spheroid aggregates incubated with growth
medium±GSK-3 inhibitors were measured using the WST-1
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assay (Roche, West Sussex, UK) in 96 well plates, according to the
manufacturer’s recommendations. Tumour spheroids were imaged
at 24 h, 48 h and 72 h using the EVOS cell imaging system and
spheroid core area was calculated using Image J software to
evaluate proliferation over time.
Statistical analysis. Statistical analysis was carried out using SPSS
version 21 (IBM, New York, NY, USA). Statistical significance
between multiple groups was determined by ANOVA. P-values
o0.05 were considered statistically significant.
RESULTS
Paediatric glioma cell lines form tumour spheroids displaying
different patterns of migration. In this study, we sought to
identify chemotherapeutic agents capable of impairing migration
and invasion in pHGG and DIPG cell lines. Tumour spheroids
represent a useful model for examining tumour biology in vitro as
they are three dimensional and comprise of a surface with ready
access to nutrients and oxygen and an inner hypoxic core (Nowicki
et al, 2008). Moreover, once embedded in a matrix such as
collagen, cells can migrate outward from the core representing a
model of the process of invasion (Nowicki et al, 2008).
Two pHGG cell lines, SF188 (glioblastoma) and KNS42
(glioblastoma) and one patient-derived DIPG cell line, HSJD-
DIPG-007, were first examined for their ability to form spheroids
in culture. Similar to Vinci et al (2012), we noted that all three cell
lines readily formed round dense spheroids within 24 h when
cultured in low adherence 96-well round bottomed plates
(Figure 1A). Paediatric glioma tumour spheroids were then
embedded in collagen, and cell migration was monitored over
72 h by light microscopy. The cell lines exhibited distinct migratory
characteristics and migration patterns were strikingly different
(Figure 1B): SF188 displayed a cogwheel pattern of migration with
what appeared to be long thin symmetrical protrusions branching
from the central core, whereas KNS42 and HSJD-DIPG-007
migrated by extending flattened protrusions and spreading in a
sheet-like manner. The observed differences were also reflected in
the migration indices obtained for the migration edge for each cell;
KNS42 migrated significantly less than SF188 and HSJD-DIPG-
007 (migration index 0.59). No significant difference was observed
between the migration index of SF188 (0.87) and HSJD-DIPG-007
(0.78) (Figure 1C).
LiCl and BIO inhibit migration and invasion of paediatric
glioma cells in 3D spheroid assays. The small molecule GSK-3
inhibitors, LiCl and the indirubin derivative BIO, have recently
been shown to block migration in adult glioblastoma cell lines
(Nowicki et al, 2008; Williams et al, 2011). Moreover, indirubin
derivatives extend survival in animal glioblastoma orthotopic
xenograft models and block metastasis in vivo (Williams et al,
2011). However, whether these agents exert similar effects upon
migration and invasion in pHGG and DIPG cell lines has not been
previously determined. In order to answer this question, tumour
spheres from each cell line were embedded in collagen, overlaid
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Figure 1. Paediatric glioma cell lines readily form tumour spheres from monolayers and demonstrate different patterns of migration.
(A) The paediatric glioblastoma cell lines SF188 and KNS42 and the patient-derived DIPG cell line HSJD-DIPG-007 were evaluated for their ability
to form tumour spheres in low adherent 96 well round-bottomed plates. After 72 h of incubation, all three cell lines formed tumour spheres.
Images at 100 magnification. (B) SF188, KNS42 and HSJD-DIPG-007 tumour spheroids were capable of migrating after embedding in a
collagen matrix as demonstrated at time point 72 h. Images at 40 magnification, scale bar¼ 1000mm. (C) The paediatric glioma cell lines
differed in their ability to migrate as determined by the migration index (MI) for the invasion front and the leading edge. Error bars expressed as
±s.e.m. ***Po0.001 by T test. Results are representative of n¼3 individual experiments.
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with the drugs at varying concentrations and migration and
invasion were imaged over 72 h (Figure 2A and B). A migration
index was then calculated for each condition to compare the
invasion front and leading edge zone for each treatment
(Figure 2C).
We found that LiCl and BIO reduced migration and invasion in
a concentration-dependent manner (Figure 2C). After 72 h, 10 or
5 mM BIO significantly blocked invasion of both pHGG cell lines
(Figure 2C) (mean±s.e.m. SF188 leading edge; control medium
0.869±0.014, BIO 10 mM 0.292±0.069 Po0.001, BIO 5mM
NaCl
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Figure 2. Inhibition of paediatric glioma tumour sphere invasion by LiCl and BIO. Tumour spheroids (SF188) were embedded in collagen and
incubated in (A) LiCl at 40, 20, 10, 5mM in NaCl or (B) BIO at 10, 5, 1, 0.5mM in DMSO for 72 h. Migration was inhibited by both LiCl and
BIO as shown in representative stills at 24, 48 and 72h using the EVOS cell imaging system at  40 magnification. Scale bar¼1000mm.
(C) Quantitative analysis of migration inhibition confirmed the results visualised by microscopy. Control medium used was Dulbecco’s Modified
Eagles’ medium plus 10% heat-inactivated foetal calf serum. Both LiCl and BIO had statistically significant anti-migratory effects on the invasion
zone and leading edge as indicated by * on all three cell lines (SF188, KNS42 and HSJD-DIPG-007). Results are representative of n¼3 individual
experiments. Error bars expressed as ±s.e.m. *Po0.05, **Po0.01, ***Po0.001 by ANOVA for each cell type and treatment. (D) Cell viability of
paediatric glioma lines (SF188 and KNS42) grown as tumour spheroids treated with various concentrations of LiCl and BIO was determined by
WST-1 assay and then expressed as a percentage of controls. Error bars expressed as±s.e.m. The effects of LiCl and BIO on b-catenin localisation
were evaluated for SF188 (E) and KNS42 (F) compared with medium mock-treated controls by immunofluorescent labelling. Arrows indicate
b-catenin localisation. Red labelling–b-catenin, green labeling–actin, blue labeling–DAPI staining. Magnification 63.
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0.401±0.065 Po0.001 KNS42 leading edge; control medium
0.587±0.31, BIO 10 mM 0.157±0.036 Po0.001, BIO 5 mM
0.166±0.033 Po0.001). The invasion of the DIPG cell line
at 72 h was significantly blocked by BIO at both 5 and 1 mM
(mean±s.e.m. HSJD-DIPG-007 leading edge; control medium
0.784±0.1, BIO 5 mM 0.0 Po0.001, BIO 1 mM 0.36±0.040
Po0.001). Treatment with 40 and 20mM LiCl for 72 h also caused
a statistically significant reduction of invasion for SF188 and
KNS42 (for both the invasion front and leading edge (Figure 2C))
(mean±s.e.m. SF188 leading edge; control medium 0.869±0.014,
LiCl 40mM 0.256±0.042 Po0.001, LiCl 20mM 0.667±0.05
P¼ 0.005, KNS42 control medium 0.587±0.31, LiCl 40mM
0.123±0.02 Po0.001, LiCl 20mM 0.112±0.026 Po0.001). LiCl
at 20mM and 5mM significantly reduced the invasion of HSJD-
DIPG-007 following 72 h of treatment (mean±s.e.m. HSJD-DIPG-
007 leading edge; control medium 0.784±0.1, LiCl 20mM
0.19±0.92 Po0.01, LiCl 5mM 0.322±0.11 Po0.05).
To confirm that the observed effects on migration after drug
treatment were the result of specific anti-migratory effects and not
caused by non-specific cytotoxic or anti-proliferative effects, we
investigated the effects of the two inhibitors on spheroid viability
by WST-1 assays. This assay has previously been used to determine
the viability of cells grown as spheroids (Van Beusechem et al,
2003). In the 3D spheroid system, both pHGG cell lines displayed
viability of at least 75% or above for all treatments with LiCl and
BIO (Figure 2D). Proliferation, as determined by spheroid core size
changed over time, was only reduced at 40mM LiCl in SF188
(Supplementary Figure 2).
The effect of LiCl and BIO on migration has previously been
investigated in adult glioma and their anti-migratory activity has
been attributed to their ability to inhibit GSK-3 and stabilise
b-catenin (Nowicki et al, 2008; Williams et al, 2011). In order to
confirm that LiCl and BIO target GSK-3 in pHGG, we carried out
western blot analysis of the activated and inactivated forms of GSK-3
protein. LiCl increased Ser9 phosphorylated GSK-3b (inactivated
form) and BIO decreased the activating tyrosine of GSK-3ab
(Supplementary Figure 3). Next, we examined b-catenin localisation
and staining by IF post treatment (Figure 2E and F). For SF188, cells
treated with both LiCl or BIO displayed reduced staining of b-catenin
at the plasma membrane with enhanced cytoplasmic and peri-
nuclear staining. This was more marked for cells treated with BIO
than LiCl (Figure 2E). For KNS42, surface and intracellular staining
of b-catenin was observed in the control; however, BIO and LiCl
treatment resulted in internalisation of b-catenin, which was more
pronounced for BIO treatment (Figure 2F).
Migration of paediatric HGG cells in transwell assays is
inhibited after treatment with LiCl and BIO. In order to
confirm the anti-migratory effects of LiCl and BIO observed in
the spheroid model, a 2D transwell assay was performed. Both
pHGG cell lines were able to migrate through the transwell
membranes, with SF188 demonstrating the most migration over
4 h (data not shown). In the transwell experiments, treatment with
20mM LiCl and 5mM BIO reduced cell migration in both SF188
and KNS42 confirming the results obtained from the spheroid
assays (Figure 3A). Five micromoles of BIO reduced migration in
both pHGG cell lines and reached statistical significance for
KNS42. Treatment with 20mM LiCl also reduced migration in both
cell lines and reached statistical significance for SF188. We
conclude that at concentrations of 20mM and 5mM respectively,
LiCl and BIO have significant anti-migratory effects on pHGG
cells. Consequently, all subsequent migration assays and IF studies
were performed on cells treated with LiCl or BIO at these
concentrations. Additionally, at the same highest concentrations of
NaCl or DMSO, no adverse effects on cell biology were observed;
thus, we carried out all subsequent experiments using growth
medium (Dulbecco’s Modified Eagles’ medium plus 10% heat-
inactivated foetal calf serum) as the control.
Next, we assessed the effect of LiCl and BIO treatment on cell
monolayer viability via a WST-1 assay over a time course of 72 h
(Figure 3B). SF188 was the most sensitive cell line to both
treatments. At 24 h, which would most closely correlate to the time
scale for the transwell assay, both cell lines demonstrated greater
than 80% viability when treated with LiCl. SF188 was more
sensitive to 10 mM BIO at 24 h, with cell viability at 57%; however,
KNS42 was resistant to the effects of BIO with greater than 90%
cell viability demonstrated at 24 h. Over 72 h, when cultured as
monolayers, both pHGG cell lines exhibited increased sensitivity to
LiCl and BIO treatment compared with spheroid cultures. This is
unsurprising because 3D aggregates of tumour cells, including
pHGG cells, have been shown to be generally more drug resistant
than 2D cultures (Mehta et al, 2012; Smith et al, 2012). Finally, to
demonstrate that LiCl and BIO are not directly cytotoxic at
concentrations of 20mM and 5mM respectively, monolayers of both
pHGG cell lines were imaged by time lapse microscopy following
treatment with LiCl and BIO for 24 h. After 24 h, the drugs were
removed, and both pHGG cell lines demonstrated recovery and
resumed their normal morphology (results not shown).
LiCl and BIO inhibit paediatric HGG cell migration on a
topographic nanofibre-based migration assay. A nanofibre-based
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assay was also used to assess the effect of GSK-3 inhibition on
migration of pHGG cell lines on a 3D scaffold. This assay utilises
aligned fibres of polycaprolactone to stimulate cell migration via
topographic cues (Johnson et al, 2009). When cells are plated on the
nanofibre scaffold they adhere, elongate and move along the fibre
axis (Figure 4A).
Firstly, we noted that each pHGG cell line was able to migrate in
this model system and further confirmation of the anti-migratory
effect of the GSK-3 inhibitors LiCl and BIO was obtained. As seen
in previous assays, SF188 was the most migratory cell line in terms
of distance travelled. Perimeter indices (% increase from the
spheroid perimeter to the perimeter marking the migrated cells)
were calculated for each cell line. Treatment with LiCl and BIO
decreased the migration index (Figure 4B) and perimeter index
(Figure 4C) for both pHGG cell lines when compared with
controls. However, the effect was more marked for KNS42 when
compared with SF188.
Live cell imaging of paediatric HGG cell line migration. Given
the accumulation of evidence that LiCl and BIO are able to reduce
the migration of SF188 and KNS42 cells, we went on to hypothesise
that we should be able to detect direct changes in cell morphology
and motility following treatment. We investigated the effects of
LiCl and BIO on individual cell morphology by live cell imaging
over 24 h. SF188 and KNS42 cells were incubated with 20mM LiCl,
5 mM BIO or control medium and time lapse imaging was
performed for 24 h (Figure 5A and B). In terms of motility,
SF188 cells were more motile and demonstrated greater velocity
than KNS42 cells (mean±s.e.m. velocity SF188 control
0.295±0.0018mmmin 1 KNS42 control 0.0599±0.0048mmmin 1)
(Figure 5C–E). Cells from both lines were able to polarise under
normal conditions; however, treatment with 20mM LiCl and 5mM
BIO reduced polarity as demonstrated by a reduction in
displacement, but this did not reach statistical significance
(displacement SF188 control 176.5±74.6, LiCl 20mM 52.5±15.3,
BIO 5mmol 107.2±61.7, KNS42 control 28.6±8.23, LiCl 20mM
14.7±2.35, BIO 5 mmol 14.19±1.9). Twenty millimoles of LiCl
and 5mM BIO reduced the velocity of SF188 cells (control
0.295±0.0018 mmmin 1, LiCl 20mM 0.153±0.047 mmmin 1
P¼ 0.049, BIO 5 mmol 0.21±0.041 mmmin 1 P¼ 0.247)
whereas treatment only with 5mM BIO reduced the velocity
of KNS42 cells (control 0.0599±0.0048 mmmin 1, LiCl
20mM 0.0761±0.0063 mmmin 1 P¼ 0.98, BIO 5 mmol 0.0501±
0.041 mmmin 1 P¼ 0.345). LiCl and BIO appeared to have a
greater effect on the polarity of KNS42 cells than velocity. Apart
from the effects on cell motility, both LiCl and BIO appeared to
affect cell morphology with cells rounding up after treatment and
demonstrating loss of polarity and blebbing (Figure 5A and B).
Non-apoptotic plasma membrane blebbing has been implicated in
cell movement, mode of migration and disruption of actin-
membrane interactions (Fackler and Grosse, 2008). Taken
together, these observations may explain why the cells incubated
with these drugs demonstrated a reduction in migration in the
previous experiments.
Immunofluorescence studies reveal differences in cellular
morphology in paediatric HGG cell lines and morphological
changes after drug treatment. We next utilised IF techniques to
investigate the effects of the GSK-3 inhibitors on the microtubule
cytoskeleton (polarity), actin cytoskeleton (morphology, motility)
and focal adhesions (cell motility, morphology). Both cell lines
were characterised by distinctive microtubule network, actin
cytoskeleton and focal adhesion staining patterns. Immunofluor-
escence labelling revealed either elaborate microtubule networks
across the whole cell body or a more pronounced cell surface
localisation, whereas for actin we observed stress fibres, cortical
actin or a diffuse internal localisation (‘other’) and whole body,
cortical or diffuse focal adhesion labelling, which changed in
response to treatment. Untreated SF188 cells appeared as large cells
with a microtubule network, pronounced actin stress fibres and
focal adhesions across the whole cell body (Figure 6A). After
treatment with 20mM LiCl and 5 mM BIO, we observed that the
cells appeared more rounded with pronounced microtubule
localisation on the cell surface. Actin stress fibre labelling in the
control cells was marked and decreased in the cells treated with
LiCl and BIO with a more diffuse cortical and internal actin
distribution (‘other’). (Figure 6C). Focal adhesions across the cell
body were diminished after treatment with the inhibitors and,
when present, re-distributed to the surface of the cells (Figure 6D).
KNS42 cells appeared as medium-sized elongated cells with a
microtubule network and had diffuse actin stress fibres (Figure 6B).
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Figure 3. LiCl and BIO inhibit migration of pHGG cells in a 2D
Transwell assay. (A) Cells pre-treated with either control medium, LiCl
and BIO were assessed for their ability to migrate across a transwell
membrane after 4 h incubation. At 20mM LiCl or 5 mM BIO, inhibition
of migration was observed in SF188 and KNS42. Results are
representative of n¼ 3 individual experiments. Error bars are expressed
as ±s.e.m. *Po0.05, **Po0.01 by ANOVA for each cell type and
treatment. (B) The effect of LiCl and BIO at various concentrations on
the paediatric glioma lines (SF188 and KNS42) grown as monolayers
was assessed by a WST-1 assay and was expressed as a percentage of
controls. Results are representative of n¼3 individual experiments.
Error bars expressed as ±s.e.m. *Po0.05, **Po0.01, ***Po0.001 by
ANOVA for each cell type and treatment.
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Focal adhesions appeared to be associated with actin filaments in
untreated cells. After addition of the inhibitors, the cells rounded
up and were smaller in comparison to the untreated cells. The
microtubule network was still present, however, actin stress fibres
appeared to be less pronounced (especially after treatment with
BIO) (Figure 6C) and focal adhesions co-localised diffusely with
the actin filament and when present relocated to the cortex
(Figure 6D).
DISCUSSION
Paediatric high grade glioma and DIPG are devastating tumours
associated with poor prognosis and despite attempts at aggressive
therapy, tumours inevitably recur owing to their diffuse and
invasive nature. As a result, there is a need to identify and develop
novel therapeutic approaches that target and block tumour
invasion. In this study, we characterised the migratory behaviour
of two pHGG cell lines and one patient-derived DIPG cell line in
2D and 3D models and investigated their response to GSK-3
inhibitors. We have shown that different paediatric glioma cell
lines are able to grow as tumour spheroids, which are capable of
migrating through a collagen matrix. To the best of our knowledge,
this is the first time that DIPG migration has been described using
a 3D model. Each cell line investigated demonstrated a unique
pattern of migration and invasion. We also examined the motility
of individual pHGG cells via live cell imaging, which indicated
different speeds and morphology in two cell lines. In addition, we
have demonstrated for the first time that LiCl and BIO, which have
anti-invasive effects in adult glioma cell lines (Nowicki et al, 2008;
Williams et al, 2011), also inhibit the migration of paediatric
glioma cells in 2D (transwell) and 3D (spheroid invasion assay and
nanofibre plates) assays. We observed a significant inhibition of
migration with 5mM BIO and 20mM LiCl in all of our paediatric
glioma cell lines. This was not accompanied by marked loss of
viability when SF188 and KNS42 cells were cultured as multi-
cellular spheroids. Our data correlate with previously published
results for these inhibitors in adult glioma models (Nowicki et al,
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2008; Williams et al, 2011). Finally, we have shown that LiCl and
BIO treatment altered the motility of individual pHGG cells,
resulting in overall reduced movement, loss of polarity and cell
rounding. This observation is novel and demonstrates the specific
effects of LiCl and BIO on cell morphology and motility. Overall,
our study is amongst the very few to have identified existing
clinical and preclinical agents, which are capable of disrupting
migration and invasion in pHGG and DIPG cell lines.
Cell migration may be achieved by a set of component
processes, which are often regulated by the same effectors
regardless of the cell type and the mode of migration. Broadly,
these processes are based on polarisation, protrusion and adhesion,
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translocation of the cell body and retraction of the rear. They are
also coordinated and integrated by extensive transient signalling
networks (Wehrle-Haller and Imhof, 2003). We therefore inves-
tigated the effect of LiCl and BIO on the interaction between the
microtubule cytoskeleton, actin skeleton and focal adhesions on
two established pHGG cell lines that grow as monolayers. In both
pHGG cell lines examined, we observed that microtubules re-
localised to the surface of cells. There was a change in the actin
cytoskeleton with re-localisation of the actin fibres to the cell
periphery and we also noted a change in focal adhesion point turn
over and dynamics with a marked re-distribution of focal adhesion
points to the cell surface or apparent loss of focal adhesion foci.
The cells appeared to be immobilised in response to the loss of
polarity, motility and attachment-detachment dynamics, account-
ing for their inability to migrate.
One postulated mechanism for the anti-migratory effects of LiCl
and BIO is through GSK-3 inhibition. Glycogen synthase kinase-3
is thought to be involved in the control of cell migration, through
its role in regulating cellular structure alongside microtubule and
focal adhesion dynamics (Grimes and Jope, 2001; Sun et al, 2009).
In adult HGG, the effect of LiCl and BIO on migration has
previously been investigated and their anti-migratory activity has
been attributed to their ability to inhibit GSK-3 and stabilise
b-catenin via the canonical Wnt signalling pathway (Luo, 2009).
In adult glioma models, LiCl has been shown to increase b-catenin
reporter activity and b-catenin knockdown has been demonstrated
to rescue the anti-migratory effects of BIO (Nowicki et al, 2008;
Williams et al, 2011). In our study, we examined b-catenin
localisation by IF post treatment of pHGG cells with LiCl and BIO,
and observed a marked internalisation of b-catenin to the
cytoplasm and nucleus following treatment. This observation has
also been noted in adult glioma following LiCl and BIO treatment
(Williams, 2011) and provides evidence to support the effectiveness
of LiCl and BIO as an inhibitor of GSK-3. Furthermore, western
blot analysis of our pHGG lines confirmed that LiCl increased Ser9
phosphorylated GSK-3b (inactivated form) and BIO decreased the
activating tyrosine of GSK-3ab.
Both LiCl and BIO have potential for clinical application. LiCl
has been used to treat psychiatric conditions such as bipolar
disorder for many decades (Mitchell, 1999) and BIO is part of the
family of indirubins, which have been identified as the active
ingredient of the Chinese medicine Danggui Longhui Wan, which
has anti-leukemic activity (Hoessel et al, 1999). Other GSK-3
inhibitors have been developed and tested in a variety of preclinical
studies (Meijer et al, 2004; Eldar-Finkelman and Martinez, 2011),
however, current hurdles for the use of such drugs in clinical
practice include optimisation of drug delivery and avoidance of
toxic systemic accumulation of the drug. In particular, LiCl has a
narrow therapeutic window, inducing nephrotoxicity at concentra-
tions greater than 1.5mM in vivo (Nowicki et al, 2008). Although our
data detect significant anti-migratory effects on paediatric glioma at
concentrations as low as 5mM, alternative methods of drug delivery
such as convection-enhanced delivery or local delivery with
polymers may be required to attain localised high concentrations
of the drug in human brain tumours (Nowicki et al, 2008; Siegal,
2013) and this requires further evaluation in vivo with preclinical
models. Alternatively, the development of specific novel GSK-3
inhibitors capable of crossing the blood–brain barrier at concentra-
tions associated with clinically acceptable side effect profiles will help
overcome this problem. Finally, owing to the lack of published
mouse models of paediatric glioma invasion, we have not been able
to address the anti-migratory effects of GSK-3 inhibitors in vivo.
Studies of adult glioma have shown that GSK-3 inhibitors of the
indirubin family are able to reduce invasion of glioma cells in vivo
(Williams et al, 2011) and development of a paediatric orthotopic
xenograft model of migration to test novel GSK-3 inhibitors forms a
major part of our ongoing studies in this area.
In summary, we have characterised the migratory behaviour of
paediatric glioma cell lines in 2D and 3D models and conclude that
GSK-3 inhibitors, such as LiCl and BIO, may be novel candidates
for migration inhibition in pHGG and DIPG and as such warrant
further investigation as therapeutics for this challenging group of
tumours.
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